(Q26824579)

4

0 references

Tanuja Chitnis

6

0 references

Benjamin M. Greenberg

object named as

Benjamin Greenberg

9

1 reference

ORCID Public Data File 2021

Brian G Weinshenker

19

object named as

Brian G. Weinshenker

1 reference

Dean M. Wingerchuk

1

1 reference

Brenda Banwell

2

1 reference

Jeffrey L. Bennett

3

1 reference

William Carroll

5

1 reference

Jérôme de Seze

7

1 reference

Kazuo Fujihara

8

1 reference

Anu Jacob

10

1 reference

Marco Lana-Peixoto

12

1 reference

Michael Levy

13

1 reference

Jack H. Simon

14

1 reference

Silvia Tenembaum

15

1 reference

Anthony L. Traboulsee

16

1 reference

Patrick Waters

17

1 reference

Kay E. Wellik

18

1 reference

language of work or name

1 reference

14 July 2015

3 references

25 April 2019

30 June 2019

3 references

25 April 2019

30 June 2019

85

1 reference

issue

2

1 reference

page(s)

177-89

1 reference

Creative Commons Attribution-NonCommercial-NoDerivatives

copyright license

2 references

25 April 2019

30 June 2019

The history of neuromyelitis optica

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4515040

Aquaporin 4 and neuromyelitis optica

7 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4515040

Contrasting disease patterns in seropositive and seronegative neuromyelitis optica: A multicentre study of 175 patients

7 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4515040

IgG marker of optic-spinal multiple sclerosis binds to the aquaporin-4 water channel

7 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4515040

Myelin-oligodendrocyte glycoprotein antibodies in adults with a neuromyelitis optica phenotype

7 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4515040

Distinction between MOG antibody-positive and AQP4 antibody-positive NMO spectrum disorders

7 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4515040

A serum autoantibody marker of neuromyelitis optica: distinction from multiple sclerosis

7 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4515040

Diagnostic utility of aquaporin-4 in the analysis of active demyelinating lesions

7 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4515040

Short myelitis lesions in aquaporin-4-IgG-positive neuromyelitis optica spectrum disorders

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4515040

Treatment of Neuromyelitis Optica: Review and Recommendations.

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4515040

Neuromyelitis optica spectrum disorders with aquaporin-4 and myelin-oligodendrocyte glycoprotein antibodies: a comparative study

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4515040

The pathology of an autoimmune astrocytopathy: lessons learned from neuromyelitis optica.

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4515040

Aquaporin-4 antibodies (NMO-IgG) as a serological marker of neuromyelitis optica: a critical review of the literature

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4515040

Updated estimate of AQP4-IgG serostatus and disability outcome in neuromyelitis optica.

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4515040

Aquaporin-4 antibody-negative neuromyelitis optica: distinct assay sensitivity-dependent entity.

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4515040

International Pediatric Multiple Sclerosis Study Group criteria for pediatric multiple sclerosis and immune-mediated central nervous system demyelinating disorders: revisions to the 2007 definitions.

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4515040

Distinction of seropositive NMO spectrum disorder and MS brain lesion distribution

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4515040

Serologic diagnosis of NMO: a multicenter comparison of aquaporin-4-IgG assays.

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4515040

The emerging relationship between neuromyelitis optica and systemic rheumatologic autoimmune disease

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4515040

A population-based study of neuromyelitis optica in Caucasians

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4515040

CSF complements serum for evaluating paraneoplastic antibodies and NMO-IgG.

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4515040

Neuromyelitis optica unique area postrema lesions: nausea, vomiting, and pathogenic implications

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4515040

Neuromyelitis optica IgG serostatus in fulminant central nervous system inflammatory demyelinating disease

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4515040

Posterior reversible encephalopathy syndrome in neuromyelitis optica spectrum disorders

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4515040

An epidemiological study of neuromyelitis optica in Cuba

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4515040

Antibody to aquaporin-4 in the long-term course of neuromyelitis optica

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4515040

CNS aquaporin-4 autoimmunity in children

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4515040

The spectrum of neuromyelitis optica

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4515040

Migration and multiple sclerosis: the French West Indies experience

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4515040

Neuromyelitis optica brain lesions localized at sites of high aquaporin 4 expression

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4515040

Revised diagnostic criteria for neuromyelitis optica

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4515040

Brain abnormalities in neuromyelitis optica

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4515040

Neuromyelitis optica with hypothalamic involvement

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4515040

The clinical course of neuromyelitis optica (Devic's syndrome).

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4515040

Epidemiologic and clinical studies of multiple sclerosis in Japan

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4515040

Seroprevalence of aquaporin-4-IgG in a northern California population representative cohort of multiple sclerosis

31 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4515040

Brainstem manifestations in neuromyelitis optica: a multicenter study of 258 patients.

28 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4515040

The usefulness of brain MRI at onset in the differentiation of multiple sclerosis and seropositive neuromyelitis optica spectrum disorders

28 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4515040

Aquaporin-4 antibody-positive cases beyond current diagnostic criteria for NMO spectrum disorders.

28 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4515040

Long-term follow-up of acute partial transverse myelitis.

28 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4515040

Failure of natalizumab to prevent relapses in neuromyelitis optica.

28 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4515040

Development of extensive brain lesions following fingolimod (FTY720) treatment in a patient with neuromyelitis optica spectrum disorder.

28 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4515040

Cerebrospinal fluid findings in aquaporin-4 antibody positive neuromyelitis optica: Results from 211 lumbar punctures

28 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4515040

Brain abnormalities as an initial manifestation of neuromyelitis optica spectrum disorder.

28 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4515040

Long-term follow-up of neuromyelitis optica with a pediatric onset.

28 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4515040

Characteristic brain magnetic resonance imaging abnormalities in central nervous system aquaporin-4 autoimmunity

28 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4515040

Occurrence of acute large and edematous callosal lesions in neuromyelitis optica

28 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4515040

NMO-IgG predicts the outcome of recurrent optic neuritis

28 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4515040

Immunosuppressive therapy is more effective than interferon in neuromyelitis optica.

28 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4515040

Intractable hiccup and nausea with periaqueductal lesions in neuromyelitis optica

28 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4515040

Recurrent optic neuromyelitis with endocrinopathies: a new syndrome.

28 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4515040

Neuromyelitis optica IgG predicts relapse after longitudinally extensive transverse myelitis

28 November 2018

1 reference

12 December 2020

Neuromyelitis optica IgG status in acute partial transverse myelitis

1 reference

12 December 2020

A secondary progressive clinical course is uncommon in neuromyelitis optica

1 reference

12 December 2020

Neuromyelitis optica-IgG in childhood inflammatory demyelinating CNS disorders

1 reference

12 December 2020

Intractable vomiting as the initial presentation of neuromyelitis optica

1 reference

12 December 2020

Brain abnormalities in neuromyelitis optica

1 reference

12 December 2020

Clinical features of neuromyelitis optica in a large Japanese cohort: comparison between phenotypes

1 reference

12 December 2020

Painful tonic spasm in neuromyelitis optica: incidence, diagnostic utility, and clinical characteristics

1 reference

12 December 2020

Evaluation of aquaporin-4 antibody assays.

1 reference

12 December 2020

10.1212/WNL.0000000000001729

Identifiers

DOI

1 reference

1 reference

1 reference

PubMed publication ID

26092914

1 reference